Professor of Medicine, Dana-Farber Cancer Institute
Hematology
Dr. Jerome Ritz, MD
|
|
Give Review
Jerome Ritz, MD practices Hematology. He has 2 awards "Elected Member" and "Super Doctor". Dr. Jerome Ritz has written publications. He has 36 publications published with PubMed. The lastest paper is: 'Circulating T follicular helper cells with increased function during chronic graft-versus-host-disease.'
Publications
- Circulating T follicular helper cells with increased function during Chronic graft-versus-host-disease.
- A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A P...
- Angiogenic Cytokines Are Antibody Targets During Graft-versus-Leukemia Reactions.
- Reprint of: B cells in Chronic graft-versus-host disease.
- Absolute Lymphocyte Count Recovery after Allogeneic Hematopoietic Stem Cell Transplantation Predicts Clinical Outcome.
- B Cells in Chronic Graft-versus-Host Disease.
- Sequential infusion of donor-derived dendritic cells with donor lymphocyte infusion for relapsed hematologic cancers after allogeneic hematopoietic stem cell transplan...
- A Phase II Study of Bortezomib Plus Prednisone for Initial Therapy of Chronic Graft-versus-Host Disease.
- Somatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem-cell transplantation.
- Systematic identification of personal tumor-specific neoantigens in Chronic lymphocytic leukemia.
- Donor Chimerism Early after Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation Predicts Relapse and Survival.
- Current issues in Chronic graft-versus-host disease.
- Increased T follicular helper cells and germinal center B cells are required for Chronic GVHD (cGVHD) and bronchiolitis obliterans.
- Factors associated with bronchiolitis obliterans syndrome and Chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation.
- White blood cell recovery after allogeneic hematopoietic cell transplantation predicts clinical outcome.
- Post-Transplantation B Cell Activating Factor and B Cell Recovery before Onset of Chronic Graft-versus-Host Disease.
- Aberrant expression of SALL4 in acute B cell lymphoblastic Leukemia: Mechanism, function, and implication for a potential novel therapeutic target.
- Reversal of in situ T cell exhaustion during effective human anti-Leukemia responses to donor lymphocyte infusion.
- Prostaglandin-modulated umbilical cord blood hematopoietic stem cell transplantation.
- ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death.
- A phase I study of escalated dose subcutaneous alemtuzumab given weekly with rituximab in relapsed Chronic lymphocytic leukemia/small lymphocytic lymphoma.
- Low-dose interleukin-2 therapy restores regulatory T cell homeostasis in patients with Chronic graft-versus-host disease.
- Low levels of 25-hydroxyvitamin D before allogeneic hematopoietic SCT correlate with the development of Chronic GVHD.
- Identification of Cytolytic CD161(-)CD56(+) Regulatory CD8 T Cells in Human Peripheral Blood.
- A Phase I Study of Alemtuzumab for Therapy of Steroid-Refractory Chronic Graft-versus-Host Disease.
- Long-term follow-up of reduced-intensity allogeneic stem cell transplantation for Chronic lymphocytic leukemia: prognostic model to predict outcome.
- KIR ligand incompatibility is not associated with relapse reduction after double umbilical cord blood transplantation.
- Airway dilation in bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation.
- Expression of ñ4ò7 integrin on memory CD8(+) T cells at the presentation of acute intestinal GVHD.
- Detecting T-cell reactivity to whole cell vaccines: Proof of concept analysis of T-cell response to K562 cell antigens in CML patients.
- Development and implementation of a computerized system for collection, processing, and administration of cellular therapy products.
- Expression of CD30 in patients with acute graft-vs.-host disease.
- Altered B-cell homeostasis and excess BAFF in human Chronic graft-versus-host disease.
- Protein disulfide isomerases are antibody targets during immune-mediated tumor destruction.
- Prostaglandin E2 promotes survival of naive UCB T cells via the Wnt/β-catenin pathway and alters immune reconstitution after UCBT.
Schools
Rosalind Franklin University Of Medicine ScienceThe Chicago Medical School
University Wisc Hosps
Beth Israel Hospital
Conditions Treated
- Chronic Myeloid Leukemia (CML)
- Myeloproliferative Disorders
Doctors Specialties
- Hematology
Accepted Insurances
Awards
- Elected Member
- Super Doctor
Education
-
University of Wisconsin -
Rosalind Franklin University of Medicine and Science
Hospital
-
Massachusetts General Hospital -
Dana-Farber Cancer Institute -
Brigham and Women's Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Nikhil C. Munshi, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Judy E. Garber, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James E. Bradner, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Catherine J. Wu, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Robert J. Mayer, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Mary-Ellen Taplin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susana M. Campos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Kala Seetharaman, MB
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Xiangyun He, MD |
|
|
Dr. Philippe Armand, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph H. Antin, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|